Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/PEAK1_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/PEAK1_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/PEAK1_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
GC | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/GC/PEAK1_pca_on_diff_genes.png) | CAG: Chronic atrophic gastritis |
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia |
CSG: Chronic superficial gastritis |
GC: Gastric cancer |
SIM: Severe intestinal metaplasia |
WIM: Wild intestinal metaplasia |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/PEAK1_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/PEAK1_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/PEAK1_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/PEAK1_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/PEAK1_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00901092 | Colorectum | MSS | regulation of cell-substrate junction assembly | 22/3467 | 66/18723 | 2.89e-03 | 2.24e-02 | 22 |
GO:00108104 | Colorectum | FAP | regulation of cell-substrate adhesion | 68/2622 | 221/18723 | 9.67e-11 | 2.96e-08 | 68 |
GO:00343293 | Colorectum | FAP | cell junction assembly | 105/2622 | 420/18723 | 1.03e-09 | 2.18e-07 | 105 |
GO:00315893 | Colorectum | FAP | cell-substrate adhesion | 93/2622 | 363/18723 | 2.48e-09 | 4.61e-07 | 93 |
GO:00070443 | Colorectum | FAP | cell-substrate junction assembly | 36/2622 | 95/18723 | 6.03e-09 | 9.48e-07 | 36 |
GO:01501153 | Colorectum | FAP | cell-substrate junction organization | 37/2622 | 101/18723 | 1.09e-08 | 1.33e-06 | 37 |
GO:00019523 | Colorectum | FAP | regulation of cell-matrix adhesion | 42/2622 | 128/18723 | 4.73e-08 | 3.86e-06 | 42 |
GO:00071603 | Colorectum | FAP | cell-matrix adhesion | 63/2622 | 233/18723 | 1.13e-07 | 7.43e-06 | 63 |
GO:00480413 | Colorectum | FAP | focal adhesion assembly | 31/2622 | 87/18723 | 3.40e-07 | 1.86e-05 | 31 |
GO:00518933 | Colorectum | FAP | regulation of focal adhesion assembly | 22/2622 | 66/18723 | 5.46e-05 | 1.09e-03 | 22 |
GO:00901093 | Colorectum | FAP | regulation of cell-substrate junction assembly | 22/2622 | 66/18723 | 5.46e-05 | 1.09e-03 | 22 |
GO:01501163 | Colorectum | FAP | regulation of cell-substrate junction organization | 23/2622 | 71/18723 | 6.19e-05 | 1.21e-03 | 23 |
GO:00344464 | Colorectum | FAP | substrate adhesion-dependent cell spreading | 30/2622 | 108/18723 | 1.32e-04 | 2.12e-03 | 30 |
GO:00467773 | Colorectum | FAP | protein autophosphorylation | 52/2622 | 227/18723 | 1.88e-04 | 2.76e-03 | 52 |
GO:19018882 | Colorectum | FAP | regulation of cell junction assembly | 47/2622 | 204/18723 | 3.25e-04 | 4.16e-03 | 47 |
GO:00108105 | Colorectum | CRC | regulation of cell-substrate adhesion | 57/2078 | 221/18723 | 6.94e-10 | 2.60e-07 | 57 |
GO:00315894 | Colorectum | CRC | cell-substrate adhesion | 78/2078 | 363/18723 | 6.22e-09 | 1.49e-06 | 78 |
GO:00343294 | Colorectum | CRC | cell junction assembly | 83/2078 | 420/18723 | 1.08e-07 | 1.29e-05 | 83 |
GO:00070444 | Colorectum | CRC | cell-substrate junction assembly | 29/2078 | 95/18723 | 2.34e-07 | 2.27e-05 | 29 |
GO:01501154 | Colorectum | CRC | cell-substrate junction organization | 30/2078 | 101/18723 | 2.85e-07 | 2.54e-05 | 30 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PEAK1 | SNV | Missense_Mutation | rs756989281 | c.4865G>A | p.Arg1622Gln | p.R1622Q | Q9H792 | protein_coding | tolerated(0.42) | possibly_damaging(0.51) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
PEAK1 | SNV | Missense_Mutation | | c.4618G>A | p.Glu1540Lys | p.E1540K | Q9H792 | protein_coding | tolerated(0.13) | possibly_damaging(0.575) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
PEAK1 | SNV | Missense_Mutation | novel | c.1915N>C | p.Ala639Pro | p.A639P | Q9H792 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AC-A5EH-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PEAK1 | SNV | Missense_Mutation | rs781337850 | c.4726C>T | p.Arg1576Cys | p.R1576C | Q9H792 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PEAK1 | SNV | Missense_Mutation | novel | c.2651N>G | p.Asn884Ser | p.N884S | Q9H792 | protein_coding | deleterious(0.03) | benign(0.054) | TCGA-AR-A1AM-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
PEAK1 | SNV | Missense_Mutation | | c.80A>G | p.His27Arg | p.H27R | Q9H792 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-D8-A140-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin+cyclophosphamid | SD |
PEAK1 | SNV | Missense_Mutation | rs749774987 | c.4906N>T | p.Arg1636Trp | p.R1636W | Q9H792 | protein_coding | tolerated(0.25) | benign(0.001) | TCGA-E2-A156-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
PEAK1 | SNV | Missense_Mutation | | c.73A>T | p.Ser25Cys | p.S25C | Q9H792 | protein_coding | deleterious(0) | probably_damaging(0.935) | TCGA-E2-A1LL-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | docetaxel | PD |
PEAK1 | SNV | Missense_Mutation | rs200619883 | c.4907G>A | p.Arg1636Gln | p.R1636Q | Q9H792 | protein_coding | tolerated(0.6) | benign(0) | TCGA-EW-A1OY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
PEAK1 | SNV | Missense_Mutation | | c.3078G>T | p.Gln1026His | p.Q1026H | Q9H792 | protein_coding | tolerated(0.17) | benign(0.365) | TCGA-GM-A2DH-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxol | CR |